Impact of lymphocytic thyroiditis on the outcome of papillary thyroid carcinoma treated with radioactive iodine I-131

Assessment of Different Radioactive Iodine Ablation Strategies in Intermediate and High Risk Papillary Thyroid Cancer

Impact of Ablative Low Dose Radio-Active Iodine after Thyroidectomy in Low–Risk Differentiated Thyroid Cancer

Impact of Post-Thyroidectomy I-123 Versus I-131 Whole Body Scan on the Outcome of Radioactive Iodine (I-131) Ablation for Differentiated Thyroid Carcinoma

Successful Complete Ablation Rate Post a Second Ablation Dose of 30 mCi Radioactive Iodine (I131) in Patients with Papillary Thyroid Cancer

Ablation outcomes of low versus high doses of radioiodine ( I) in patients with differentiated thyroid carcinoma following thyroidectomy

ASSESSMENT OF TREATMENT RESPONSE TO 131I THERAPY FOR PATIENTS WITH DIFFERENTIATED THYROID CARCINOMA IN THE PAST THREE YEARS (Single Institutional Experience)

Role and Outcome of RA131 I Therapy in Patients with Autonomous Toxic Adenoma

Effect of Different Ablative Doses of Radioactive Iodine in Patients with Differentiated Thyroid Carcinoma and Cervical Lymph Node Metastasis

Factors affecting ablation outcome in low and intermediate risk patients with differentiated thyroid cancer.